Catalyst Pharmaceutical CPRX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's total liabilities?
- Catalyst Pharmaceutical (CPRX) reported total liabilities of $134.91M in Q1 2026.
- How has Catalyst Pharmaceutical's total liabilities changed year-over-year?
- Catalyst Pharmaceutical's total liabilities increased by 17.7% year-over-year, from $114.59M to $134.91M.
- What is the long-term trend for Catalyst Pharmaceutical's total liabilities?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's total liabilities has grown at a 45.8% compound annual growth rate (CAGR), from $22.76M to $149.71M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.